Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ingalill Reinholdsson"'
Autor:
Hildur Arnardottir, Sven-Christian Pawelzik, Ulf Öhlund Wistbacka, Gonzalo Artiach, Robin Hofmann, Ingalill Reinholdsson, Frieder Braunschweig, Per Tornvall, Dorota Religa, Magnus Bäck
Publikováno v:
Frontiers in Physiology, Vol 11 (2021)
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). SARS-CoV-2 triggers an immune response with local inflammation in the lung, which may extend to a systemic hyperinflammatory react
Externí odkaz:
https://doaj.org/article/5b3a8175eda043468839ae9202f81f17
Autor:
Hildur, Arnardottir, Sven-Christian, Pawelzik, Ulf, Öhlund Wistbacka, Gonzalo, Artiach, Robin, Hofmann, Ingalill, Reinholdsson, Frieder, Braunschweig, Per, Tornvall, Dorota, Religa, Magnus, Bäck
Publikováno v:
Frontiers in Physiology
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). SARS-CoV-2 triggers an immune response with local inflammation in the lung, which may extend to a systemic hyperinflammatory react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc2a68210cd2fa07d962af71dbb189e9
https://pubmed.ncbi.nlm.nih.gov/33505321
https://pubmed.ncbi.nlm.nih.gov/33505321
Autor:
Matts Kågedal, Olof Borgå, Dag Nilsson, Yi-Fang Cheng, Ingalill Reinholdsson, Gunilla Huledal, Nils Åsenblad, David Pekar
Publikováno v:
The Journal of Clinical Pharmacology. 47:1043-1048
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88011d498149915b1b467695b38c9d77
https://doi.org/10.1177/0091270007303769
https://doi.org/10.1177/0091270007303769
Autor:
Gunilla Huledal, Olof Borgå, Mischa van Hout, Ingalill Reinholdsson, Matts Kågedal, Hanna Svensson, Dag Nilsson, Yi‑Fang Cheng
Publikováno v:
Current Medical Research and Opinion. 23:1531-1539
NXY-059 is a novel free-radical trapping neuroprotectant. Digoxin treatment is common in acute ischaemic stroke, the intended patient population for NXY-059. Since both digoxin and NXY-059 are eliminated primarily renally, with a substantial contribu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970193bc5eb40a2a5b496b3ffb813b1a
https://doi.org/10.1185/030079907x199646
https://doi.org/10.1185/030079907x199646
Autor:
Hanna Svensson, Bror Jonzon, Hans Quiding, Christian Åkermark, Märta Segerdahl, Ingalill Reinholdsson
Publikováno v:
PainReferences. 154(11)
A randomized, double-blind, three-period cross-over study was performed to characterize the sensory phenotype and pain demographics in patients with Morton neuroma ( n = 27) and to explore the effects of local administration (2 mL) of placebo and lid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f060b7e8dd9609f0345ef1031c7430ba
https://pubmed.ncbi.nlm.nih.gov/23886521
https://pubmed.ncbi.nlm.nih.gov/23886521
Autor:
Dag Nilsson, Wenyu Guo, Yi-Fang Cheng, Ingalill Reinholdsson, Nils Åsenblad, Pei Hu, Ji Jiang
Publikováno v:
Clinical therapeutics. 30(12)
Background: NXY-059 is a free radical-trapping neuroprotectant that has been reported to reduce infarct size and preserve brain function in experimental models of acute ischemic stroke. NXY-059 administered as an 8- or 72-hour IV infusion has been re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b0f638451243ef17217bfaed49bdcb
https://pubmed.ncbi.nlm.nih.gov/19167593
https://pubmed.ncbi.nlm.nih.gov/19167593
Autor:
Nils Egberg, Dag Nilsson, Johan Wemer, Gunnar Englund, Sam Schulman, Yi-Fang Cheng, Ingalill Reinholdsson
Publikováno v:
Journal of clinical pharmacology. 47(2)
NXY-059 is a novel free radical-trapping neuroprotectant that reduces infarct size and preserves brain function in animal models of acute ischemic stroke. It is the first neuroprotectant to demonstrate a reduction in global disability in a phase III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b63c3b206058a4c8ad98b15d7724632
https://pubmed.ncbi.nlm.nih.gov/17244778
https://pubmed.ncbi.nlm.nih.gov/17244778
Autor:
Lundström, Erik, Isaksson, Eva, Greilert Norin, Nina, Näsman, Per, Wester, Per, Mårtensson, Björn, Norrving, Bo, Wallén, Håkan, Borg, Jörgen, Hankey, Graeme J., Hackett, Maree L., Mead, Gillian E., Dennis, Martin S., Sunnerhagen, Katharina S., on the behalf of the EFFECTS Writing Committee
Publikováno v:
Stroke (00392499); Oct2021, Vol. 52 Issue 10, p3082-3087, 6p
Autor:
Arnardottir, Hildur, Pawelzik, Sven-Christian, Öhlund Wistbacka, Ulf, Artiach, Gonzalo, Hofmann, Robin, Reinholdsson, Ingalill, Braunschweig, Frieder, Tornvall, Per, Religa, Dorota, Bäck, Magnus
Publikováno v:
Frontiers in Physiology; 1/11/2021, Vol. 11, pN.PAG-N.PAG, 7p
Publikováno v:
Journal of Clinical Pharmacology; Aug2007, Vol. 47 Issue 8, p1043-1048, 6p